The Association Between Uric Acid and Symmetric Dimethylarginine Levels in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis
Keywords:
uric acid, SDMA, CAPDAbstract
Background: Uric acid (UA) levels are associated with increased risk of cardiovascular events and mortality in hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. In a study with a population of healthy young adults and HD there was a correlation between high blood uric acid levels and blood symmetric dimethylarginine (SDMA) level. However, in CAPD population, there are still conflicting data on the mechanism of increased risks related to uric acid levels. This study aimed to assess the association between uric acid levels and SDMA in the subjects undergoing CAPD. Methods: This was a cross – sectional study conducted in all the adults who underwent CAPD for at least three months in tertiary hospital in Jakarta, Indonesia. Subjects already on uric lowering therapy, pregnant or lactating women, and those with a history of malignancy were excluded. Uric acid and SDMA level were measured at the same time patients controlled to outpatient clinic. Bivariate analysis was performed using the Mann – Whitney test and multivariate analysis performed using logistic regression test. Results: A total of 55 subjects were included. The median level of UA was 7.30 + 1.59 mg/dl and 33 subjects (60%) had UA levels of 7 mg/dl or higher. The median SDMA level was 633.73 + 231.54 ng/mL. Subjects with UA levels > 7 mg/dl had significantly higher SDMA levels compared to subjects with UA levels < 7 mg/dl (721.58 + 220.57 vs 501.95 + 182; P < 0.001). The cut – off value of SDMA 536 ng/mL was obtained from the receiver operating characteristic (ROC) curve with sensitivity 81.8%, specificity 63.6%, PPV 77.78% and NPV 73.68%. After fully adjusted with the confounders, the determinant factors in this study were diabetes mellitus (OR: 7.844; CI95%: 1.899 – 32.395: P value: 0.004) and dyslipidemia (OR: 6.440; CI95%: 1.483 – 27.970; P value: 0.013) as risk factors. Conclusion: In CAPD patients, UA levels above 7 mg/dl were associated with increased SDMA levels. This study demonstrates the determinant factors regarding association between UA level and SDMA in CAPD patients were diabetes mellitus and dyslipidemia. The cut – off value of SDMA above 536 ng/mL were significant to increased risk of cardiovascular events.References
Lydia A, Widiana IGR, Bandiara R, et al. Nephrology in Indonesia. In: Divino - Filho JC, Moura - Neto JA, Ronco C, eds. Nephrology worldwide. Switzerland: Springer Nature; 2021. p. 299-312.
Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;37:28-34.
Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The framingham heart study. Ann Intern Med. 1999;131:7-13.
Madero M, Sarnak MJ, Wang X, et al. Uric acid and long term outcomes in CKD. Am J Kid Dis. 2009;53:796-803.
Chang W, Zhang W, Wang X, et al. The association of longitudinal serum uric acid and all cause mortality in incident peritoneal dialysis patients. Blood Purif. 2018:1-8.
Suliman ME, Johnson RJ, Lopez EG, et al. J - shaped mortality relationship for uric acid in CKD. Am J Kid Dis. 2006;48:761-71.
Damaso EO, Damaso NO, Esparragon FR, et al. Asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in chronic kidney disease: A clinical approach. Int J Mol Sci. 2019;20:1-15.
Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L. Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. Blood Purif. 2010;30:277-87.
Yassir. Hubungan asam urat dengan symmetric dimethyl arginine sebagai penanda penyakit kardiovaskular pada pasien hemodialisis dua kali seminggu. Jakarta: Universitas Indonesia; 2021.
Bae JH, Hyun DW, Kwon TG, Yoon HJ, Lerman A, Rihal CS. Serum uric acid is associated with cardiovascular events in patients with coronary artery disease. Korean Circulation J. 2007;37:161-6.
Dong J, Han QF, Zhu TY, et al. The association of uric acid, cardiovascular and all cause mortality in peritoneal dialysis patients. PLOS ONE. 2014;9:1-7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
